Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 18700588)

1.

Patient is the ultimate measure of any plan of therapy.

Hughes JH.

Mil Med. 2008 Jul;173(7):iii. No abstract available.

PMID:
18700588
2.

Adherence to lipid-lowering drug therapy among members of the Canadian Forces.

Ma J, Vaillancourt R, Bennett C.

Mil Med. 2008 Jul;173(7):666-70.

PMID:
18700601
3.

Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic.

O'Donnell DC, Brown CM, Piziak VK.

Am J Health Syst Pharm. 2001 Jun 1;58(11):1017-21. No abstract available.

PMID:
11402475
4.

Common obstacles in lipid management.

Elpers M.

Crit Care Nurs Clin North Am. 2008 Sep;20(3):287-95. doi: 10.1016/j.ccell.2008.03.003. Review.

PMID:
18644511
5.

Common questions in managing hyperlipidemia.

Rosen IM, Sams RW 2nd.

Prim Care. 2006 Dec;33(4):903-21. Review.

PMID:
17169673
6.

[Possibilities of the correction of disorders of lipid metabolism].

Piuretskiń≠ AI, Fisun AIa, Korol'chuk NS, Osipov AP.

Voen Med Zh. 1984 Dec;(12):58-9. Russian. No abstract available.

PMID:
6528512
7.

Drug therapy. VI. Therapy of hyperlipidemias.

Holcenberg JS, Hazzard WR.

Northwest Med. 1970 Jul;69(7):503-5. No abstract available.

PMID:
5469352
8.

Obtaining optimal compliance with drug therapy.

Cramer JA.

Manag Care. 2003 Oct;12(10 Suppl):9-11; discussion 23-5. Review. No abstract available.

9.

Vestibular vertigo associated with hyperlipidemia: response to antilipidemic therapy.

Saadah HA.

Arch Intern Med. 1993 Aug 9;153(15):1846, 1849. No abstract available.

PMID:
8333820
10.

Lipid-lowering drugs: French prescribers under pressure.

[No authors listed]

Prescrire Int. 2002 Oct;11(61):158. No abstract available.

PMID:
12378750
11.

[Treatment of hyperlipidemias].

Culig J.

Lijec Vjesn. 1985 Mar-Apr;107(3-4):146-8. Croatian. No abstract available.

PMID:
3982209
12.

Study shows poor persistence with lipid-lowering therapy, even when cost not a factor.

[No authors listed]

Am J Health Syst Pharm. 1998 Aug 1;55(15):1556, 1558. No abstract available.

PMID:
9706177
13.

Management of the elderly patient with hyperlipidaemia: recent concerns.

Kalantzi KI, Milionis HJ, Goudevenos IA.

Hellenic J Cardiol. 2006 Mar-Apr;47(2):93-9. Review. No abstract available.

14.

Guggulipid use in hyperlipidemia: case report and review of the literature.

Sahni S, Hepfinger CA, Sauer KA.

Am J Health Syst Pharm. 2005 Aug 15;62(16):1690-2. Review. No abstract available.

PMID:
16085931
15.

Managing hyperlipidemia.

[No authors listed]

Lippincott Health Promot Lett. 1997 Feb;2(2):6-7. No abstract available.

PMID:
9300892
16.

A collective failure of medical practice?

Faergeman O.

Eur Heart J. 2001 Apr;22(7):526-8. No abstract available.

17.

[Statines for all or individualized lipid lowering therapy?].

Parhofer K.

MMW Fortschr Med. 2009 Apr 2;151(14):100, 102-4; quiz 105. German. No abstract available.

PMID:
19504849
18.

Does lipid-lowering therapy slow progression of chronic kidney disease?

Wheeler DC.

Am J Kidney Dis. 2004 Nov;44(5):917-20. Review. No abstract available.

PMID:
15492960
19.

Food fortification with plant sterol/stanol for hyperlipidemia: Management in free-living populations.

Perisee DM.

J Am Diet Assoc. 2005 Jan;105(1):52-3. No abstract available.

PMID:
15635345
20.

[Current developments in lipid-lowering treatments].

Krempf M.

Ann Endocrinol (Paris). 2005 Feb;66(1):39-40. French. No abstract available.

PMID:
15798592
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk